United States · FDA National Drug Code directory
Lisdexamfetamine Dimesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65162-025_4cc5e658-25c6-4a58-a93a-6e35242d6de4
- Product NDC
- 65162-025
- Form
- CAPSULE
- Composition / generic term
- Lisdexamfetamine
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230828
- Source listing expiry
- 20271231
Source-listed ingredients
- LISDEXAMFETAMINE DIMESYLATE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 CAPSULE in 1 BOTTLE (65162-025-09) · 65162-025-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →